Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

54.11
+0.24000.45%
Volume:436.88K
Turnover:23.92M
Market Cap:1.60B
PE:-59.81
High:55.70
Open:54.58
Low:54.00
Close:53.87
52wk High:73.30
52wk Low:17.11
Shares:29.61M
Float Shares:21.05M
Volume Ratio:0.72
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9047
EPS(LYR):-0.4601
ROE:-114.55%
ROA:6.78%
PB:125.69
PE(LYR):-117.60

Loading ...

First Tracks Biotherapeutics initial beneficial ownership filing shows EcoR1 Capital stake

Reuters
·
Apr 23

AnaptysBio price target lowered to $60 from $90 at UBS

TIPRANKS
·
Apr 22

UBS Adjusts Price Target on AnaptysBio to $60 From $90, Maintains Buy Rating

MT Newswires Live
·
Apr 22

AnaptysBio Is Maintained at Buy by UBS

Dow Jones
·
Apr 22

AnaptysBio price target lowered to $60 from $90 at UBS

TIPRANKS
·
Apr 21

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Apr 21

AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge

MT Newswires Live
·
Apr 20

Anaptys Completes Separation of First Tracks Biotherapeutics and NOW Exclusively Manages GSK and Vanda Financial Collaborations

THOMSON REUTERS
·
Apr 20

AnaptysBio completes spin-off of First Tracks Biotherapeutics in corporate reorganization

Reuters
·
Apr 20

Trade Alert: Independent Director Of AnaptysBio John Schmid Has Sold Stock

Simply Wall St.
·
Apr 08

Assessing AnaptysBio (ANAB) Valuation After New Share Buyback Plan And Canceled Equity Offering

Simply Wall St.
·
Apr 06

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

TIPRANKS
·
Apr 04

AnaptysBio files Form 3 for director Susannah Gray, reporting no securities owned

Reuters
·
Apr 04

AnaptysBio director John P. Schmid disposes shares worth $1.1 million

Reuters
·
Apr 02

AnaptysBio Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Apr 01

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

AnaptysBio Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 30

AnaptysBio Spin Off Reshapes Risk Profile With New Royalty Focus

Simply Wall St.
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

BUZZ-AnaptysBio falls after board approves First Tracks Biotherapeutics spinoff

Reuters
·
Mar 27